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qualityIn the Mead study, control group patients were 2.4 years
older than patients in the experimental group and their rate
of sepsis at baseline was 3.7% higher.1 This may or may not
be statistically significant but the differences did not seem
to be clinically significant. In terms of intention to treat
analysis, only two patients out of 985 randomized patients
(0.2%) were excluded from primary analysis. Unfortunately
Jadad score does not include the assessment of randomi-
zation errors and intention to treat analysis.2 However this
degree of difference and the exclusion of two patients
would be unlikely to jeopardize the validity of study.
There are three parties that can be blinded in
a randomized controlled trial (RCT), namely patients,
treating physicians and outcome assessors. Therefore blin-
ded RCTs can be classified as “single-blind”, “double-
blind”, or “triple-blind”.3 In ventilator trials, there would
be no way that patients know the treatment assignment
since they are intubated and sedated. Treating physician
could not be blinded because the nature of the interven-
tion. We did not deduct Jadad points in the Mead study
because it was clearly stated that the outcome assessor was
blinded and, in our opinion, their study was still considered
double-blind if not triple blind for the reasons mentioned
above. In addition, it was felt that bias introduced by not
blinding treating physicians in this type of study was insig-
nificant since core outcome measures such as mortality
rates, ventilator days, and ICU length of stay were very
objective, in contrast to patient-reported outcomes, and
would not easily affected even if treating physicians knew
the treatment allocation. It is also hard to believe that
different PEEP levels affected how treating physicians
managed the patients otherwise.
That said, a quality scale such as Jadad score may no
longer be an appropriate to assess the risk of bias although
the use of Jadad score was still prevalent when our analysis
was conducted in 2008. The PRISMA statement now
recommends a component approach such as the Conchrane
Risk of Bias Tool in which assessments of risk of bias require
judgment by researchers.4,5 Although some of the included
studies in our meta-analysis had a low Jadad score, it was
felt that the risk of bias was not high enough to preclude0954-6111/$ - see front matter ª 2012 Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.rmed.2012.08.013the synthesis of data as reasoned above, which were sup-
ported by other similar studies.6,7
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